Investigation of the biological interaction and kinetics of COVID-19 antibodies after vaccination and infection and their possible interaction with platelets
- Conditions
- Immune response after vaccination against SARS-CoV-2
- Registration Number
- DRKS00029013
- Lead Sponsor
- niklinik Tübingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1139
Inclusion Criteria
Anyone over the age of 18 who is 14 days after the 2nd or 3rd vaccination or who has had a COVID-19 infection and only received one vaccination can participate. The age of admission is 18-75 years. The subjects should weigh at least 50 kg. The subject should not have any signs of infection, such as fever.
Exclusion Criteria
Subjects during pregnancy and breastfeeding are also excluded from the study.
Subjects who have received a vaccine that is not approved in Germany are also excluded.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study will be completed 12 months after full immunization or booster vaccination. <br>The goal of the study is to gain insights to better understand the long-term immune response to COVID-19 vaccination.
- Secondary Outcome Measures
Name Time Method none<br>